醣质营养素-BenV3_MannatechPresentationEnglish.pptVIP

* Dr. McAnalley knew he had a significant discovery. What he wanted to do was get some studies and some clinical trials done so he brought the product over to Dr. Reg McDaniel who was the chief of pathology at the Dallas/Fort Worth Hospital. What Dr. McDaniel did was some clinical trials and to his surprise, frankly he was quite skeptical in the beginning, he got tremendous results. Now in the 1980s only drugs could show benefits or talk about benefits. Now this molecule is a completely non-toxic food substance that supports the immune system. It’s not a drug that alters physiology. And even though that was the case, it had such benefits that they decided that they needed to bring this to market as a drug so they actually started on phase I and phase II trials to make this product a drug. As a result of that they were doing much research. And because this particular molecule is found in aloe vera, the other aloe vera manufacturers were using the science that they were developing as they were taking this molecule through as a drug to say that their aloe vera product would do the same thing. This was just not the case. * When you speak of the Royal Society of Medicine you are talking about the highest echelon of medicine. Dr. Stephen Boyd, Mannatech’s Medical Director for Health Sciences, and Dr. John Axford, a member of the Board of Directors of Mannatech are both members of the Royal Society of Medicine. This is something that I don’t think any other nutritional company can claim. Another thing that is happening right now in the world of glyconutritionals is the acceptance by the educational community. In fact, glyconutritionals are now part of the curriculum of the National College of Naturopathic Medicine and are now part of the Certified Nutrition Education Course offered by the University of Miami School of Medicine. Again, further things that heighten the validation of this amazing product. * Another thing we need to look at when we’re talking about who